Search Results - Howard Levy

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    Drotrecogin Alfa (activated) Improves In-hospital and 90-day Survival in Patients With Severe Sepsis and Community-acquired Pneumoni

    Drotrecogin Alfa (activated) Improves In-hospital and 90-day Survival in Patients With Severe Sepsis and Community-acquired Pneumoni by Richard G. Wunderink, Sachin Yende, Pierre‐François Laterre, David E. Joyce, Becky Bates, Howard Levy

    Published 2003
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Elevated Plasma Concentrations of IL-6 and Elevated APACHE II Score Predict Acute Kidney Injury in Patients with Severe Sepsis

    Elevated Plasma Concentrations of IL-6 and Elevated APACHE II Score Predict Acute Kidney Injury in Patients with Severe Sepsis by Lakhmir S. Chawla, Michael G. Seneff, David R. Nelson, Mark D. Williams, Howard Levy, Paul L. Kimmel, William L. Macias

    Published 2006
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Phase 1 Safety, Tolerability and Pharmacokinetics of 3K3A-APC in Healthy Adult Volunteers

    Phase 1 Safety, Tolerability and Pharmacokinetics of 3K3A-APC in Healthy Adult Volunteers by Patrick D. Lyden, Howard Levy, Sara Weymer, Kent E. Pryor, William G. Kramer, John H. Griffin, Thomas P. Davis, Berislav V. Zloković

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    The role of carbon monoxide and heme oxygenase in the prevention of sickle cell disease vaso‐occlusive crises

    The role of carbon monoxide and heme oxygenase in the prevention of sickle cell disease vaso‐occlusive crises by Edward D. Gomperts, John D. Belcher, Leo E. Otterbein, Thomas D. Coates, John C. Wood, Brett E. Skolnick, Howard Levy, Gregory M. Vercellotti

    Published 2017
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    Oral carbon monoxide therapy in murine sickle cell disease: Beneficial effects on vaso-occlusion, inflammation and anemia

    Oral carbon monoxide therapy in murine sickle cell disease: Beneficial effects on vaso-occlusion, inflammation and anemia by John D. Belcher, Edward D. Gomperts, Julia Nguyen, Chunsheng Chen, Fuad Abdulla, Zachary Monroe Kiser, David Gallo, Howard Levy, Leo E. Otterbein, Gregory M. Vercellotti

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Systemic Host Responses in Severe Sepsis Analyzed by Causative Microorganism and Treatment Effects of Drotrecogin Alfa (Activated)

    Systemic Host Responses in Severe Sepsis Analyzed by Causative Microorganism and Treatment Effects of Drotrecogin Alfa (Activated) by Steven M. Opal, Gary Garber, Steven P. LaRosa, Dennis G. Maki, Ross Freebairn, Gary T. Kinasewitz, Jean-François Dhainaut, S. Betty Yan, Mark D. Williams, Delores E. Graham, David R. Nelson, Howard Levy, Gordon R. Bernard

    Published 2003
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Drotrecogin Alfa (Activated) for Adults with Severe Sepsis and a Low Risk of Death

    Drotrecogin Alfa (Activated) for Adults with Severe Sepsis and a Low Risk of Death by Edward Abraham, Pierre‐François Laterre, Rekha Garg, Howard Levy, Deepak Talwar, Benjamin Trzaskoma, Bruno François, Jeffrey S. Guy, Martina Brückmann, Álvaro Réa-Neto, Rolf Rossaint, D. Perrotin, Armin Sablotzki, Nancy Arkins, Barbara G. Utterback, William L. Macias

    Published 2005
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Final Results of the RHAPSODY Trial: A Multi‐Center, Phase 2 Trial Using a Continual Reassessment Method to Determine the Safety and Tolerability of 3K3A‐APC, A Recombinant Variant of Human Activated Protein C, in Combination with Tissue Plasminogen Activator, Mechanical Thrombectomy or both in Moderate to Severe Acute Ischemic Stroke

    Final Results of the RHAPSODY Trial: A Multi‐Center, Phase 2 Trial Using a Continual Reassessment Method to Determine the Safety and Tolerability of 3K3A‐APC, A Recombinant Variant... by Patrick D. Lyden, Kent E. Pryor, Christopher S. Coffey, Merit Cudkowicz, Robin Conwit, Ashutosh P. Jadhav, Robert N. Sawyer, Jan Claassen, Opeolu Adeoye, Shlee Song, Peter Hannon, Natalia S. Rost, Archana Hinduja, Michel T. Torbey, Jin‐Moo Lee, Curtis Benesch, Michael Rippee, Marilyn M. Rymer, Michael T. Froehler, E. Clarke Haley, Mark D. Johnson, Jon Yankey, Kim Magee, Julie C. Qidwai, Howard Levy, E. Mark Haacke, Eliza C. Miller, Thomas P. Davis, Arthur W. Toga, John H. Griffin, Berislav V. Zloković

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: